Disease conditions which are dependent upon or moderated by angiogenesis
are controlled by the use of a therapeutic material which interacts with cell surface
galectins. Particular therapeutic materials comprise a polymeric backbone having
side chains terminating in a sugar dependent therefrom. Disclosed are specific
therapeutic materials in which the polymeric backbone is based upon polygalacturonic
acid, and the side chains terminate in arabinose or galactose.
